Q2 sales up 14.9%, but full-year gross margin set to decline

Management guided margin pressureInvestor Communications View source PDF Explain this filing

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹498.00

prior close

₹525.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.2%+0.7% vs market

Pharmaceuticals peers, median of 173sector+0.8%+2.1% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-2.0

15m

-1.6

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9+2.2+0.7+0.8+2.1

Next day

+4.3+3.3+1.0+1.6+2.7

+3.1pendingpending+1.5+1.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27 net sales rose 14.85% to Rs 135.18 crore and profit after tax rose 23.78% to Rs 17.28 crore. H1 sales grew 12.47% to Rs 238.15 crore, while profit after tax fell 2.77% to Rs 21.65 crore. Management expects 12-15% full-year revenue growth, but gross margin to fall 200 basis points due to packaging and pulp inflation. It targets a 12% operating margin.

Likely market impact

Sales and Q2 profit growth support shareholders, but higher input costs may limit full-year earnings.